Patents by Inventor Magdalena Winiarska

Magdalena Winiarska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 7-aminocephalosporanic acid derivative as inhibitor of IL15 and IL-2 activity
    Patent number: 11452728
    Abstract: The invention relates to a 7-aminocephalosporanic acid derivative, Cefazolin, for use as an inhibitor of IL-15 and IL-2 receptors in the prevention and treatment of diseases related to IL-15 and IL-2 overproduction.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: September 27, 2022
    Assignee: Bio Research Project PSA
    Inventors: Katarzyna Koziak, Barbara Zyzynska-Granica, Slawomir Filipek, Szymon Niewieczerzal, Bartosz Trzaskowski, Oliwia Zegrocka-Stendel, Malgorzata Dutkiewicz, Piotr Krzeczynski, Elzbieta Kaczmarek, Magdalena Winiarska
  • 7-AMINOCEPHALOSPORANIC ACID DERIVATIVE AS INHIBITOR OF IL-15 AND IL-2 ACTIVITY
    Publication number: 20170319593
    Abstract: The invention relates to a 7-aminocephalosporanic acid derivative, Cefazolin, for use as an inhibitor of IL-15 and IL-2 receptors in the prevention and treatment of diseases related to IL-15 and IL-2 overproduction.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 9, 2017
    Inventors: Katarzyna Koziak, Barbara Zyzynska-Granica, Slawomir Filipek, Szymon Niewieczerzal, Bartosz Trzaskowski, Oliwia Zegrocka-Stendel, Malgorzata Dutkiewicz, Piotr Krzeczynski, Elzbieta Kaczmarek, Magdalena Winiarska
  • 7-AMINOCEPHALOSPORANIC ACID DERIVATIVE AS INHIBITOR OF IL-15 AND IL-2 ACTIVITY
    Publication number: 20160235762
    Abstract: The invention relates to 7-zminocephalosporanic acid derivative, Cefazolin, for use as the inhibitor of IL-15 and IL-2 receptors in the prevention and treatment of IL-15 and IL-2 overproduction related diseases.
    Type: Application
    Filed: September 29, 2014
    Publication date: August 18, 2016
    Inventors: Katarzyna Koziak, Barbara Zyzynska-Granica, Slawomir Filipek, Szymon Niewieczerzal, Bartosz Trzaskowski, Oliwia Zegrocka-Stendel, Malgorzata Dutkiewicz, Piotr Krzeczynski, Elzbieta Kaczmarek, Magdalena Winiarska
  • NOVEL ANTIBODY THERAPIES
    Publication number: 20110091473
    Abstract: Antibody capable of mediating effector function which specifically binds to a multiple membrane spanning antigen or to an antigen which forms dimers or multimers (i) for use in combination with a cholesterol-increasing agent in the treatment of a disease or disorder associated with said antigen, wherein antibody-induced effector function has a beneficial effect on said disease or disorder or (ii) for use in the treatment of such disease or disorder, wherein the antibody is to be administered to a subject undergoing therapy with a cholesterol-lowering agent, such as a statin, and wherein the subject is withdrawn from treatment with the cholesterol-lowering agent prior to the administration of the antibody. Furthermore, a kit of parts comprising such antibody as well as a cholesterol-increasing agent.
    Type: Application
    Filed: October 22, 2008
    Publication date: April 21, 2011
    Applicant: GENMAB A/S
    Inventors: Jakub Golab, Magdalena Winiarska, Paul Parren, Wendy Mackus, Patrick Engelberts